CTC Workflow Clinical Validation

About Cellsway

Cellsway is a private, pre-revenue diagnostics company pioneering a microfluidic CTC liquid biopsy platform. Its integrated system combines a patented size-based enrichment device with proprietary downstream immunofluorescence assay panels to profile cancer biomarkers from blood. The company is currently conducting a 300-patient clinical study to optimize its workflow and has initiated commercial partnerships, such as with Omega Genetik in Turkey, signaling a transition towards market entry and validation.

Therapeutic Areas